Evidence map›Paper›PMID 40604790›Full record

ArticleBMC oral health2025

Clinical outcomes of a peri-implant keratinized mucosa augmentation procedure using concentrated growth factor: a prospective case series.

Lu Zhan, Yang Yang, Xiwen Zhao, Chenbing Wang, Yi Man, Yili Qu

Abstract read
In one paragraph

Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lu ZhanState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.ORCID http://orcid.org/0009-0008-3088-4966
Yang YangState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.ORCID http://orcid.org/0000-0002-3211-3638
Xiwen ZhaoState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Chenbing WangState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.ORCID http://orcid.org/0000-0001-5898-4143
Yi ManState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.ORCID http://orcid.org/0000-0002-7546-3486
Yili QuState Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China. qqyili@126.com.ORCID http://orcid.org/0000-0001-7697-3843

Funding

National Natural Science Foundation of China 82271015Science and Technology Administration of Chengdu 2022-YF09-00008-SN
6 · The paper itself

Abstract

backgroundAdequate keratinized mucosa around implants is crucial for maintaining peri-implant hard and soft tissue health. Concentrated growth factor (CGF), a novel platelet concentrate, has been widely applied to promote tissue regeneration and wound healing, which could also be effective in peri-implant keratinized mucosa augmentation. This prospective case series aimed to present the clinical outcomes of apically repositioned flap (ARF) combined with CGF and to provide histological evidence.

methodsPatients with insufficient keratinized mucosa (< 2 mm) were included. ARF combined with CGF was performed to augment the keratinized mucosa. Changes in the keratinized mucosa width (KMW) and vestibular depth (VD) from surgery to 12 months were documented. The secondary endpoints included the mucosal thickness (MT), marginal bone loss (MBL), modified plaque index (mPI), bleeding on probing (BOP), and probing depth (PD). Additionally, two biopsy samples were collected to analyze their tissue morphology and keratin expression.

resultsThirty patients with a mean age of 46.0 ± 13.4 years and a total of 48 implant sites were recruited for the study. The KMW increased significantly from 1.44 ± 0.54 mm to 5.04 ± 1.64 mm at 2 weeks and stabilized at 2.48 ± 0.80 mm over 1 year (p < 0.001). The VD improved from 4.46 ± 2.38 mm to 5.32 ± 1.93 mm at 1-year post-ARF (p < 0.001). The MT increased from 1.48 ± 0.48 mm to 2.45 ± 0.70 mm (p < 0.001). After 1 year, the mPI and BOP were 0.47 ± 0.93 and 0.17 ± 0.39, respectively. The PD and MBL were 2.39 ± 0.59 mm and 0.36 ± 0.24 mm, respectively. Histological evaluation confirmed a typical keratinized mucosal structure with appropriate expression of keratin 5 and 10.

conclusionsWithin the limitations of this case series, our findings suggested that the use of ARF combined with CGF could be a reliable approach for keratinized mucosal augmentation and vestibular deepening. KMW achieved the clinically ideal value of more than 2 mm one year after surgery. Histological analysis revealed the formation of keratinized mucosa around the implants.

Indexed as

Dental ImplantsIntercellular Signaling Peptides and ProteinsMouth MucosaAdultAlveolar Bone LossDental Plaque IndexFemaleHumansKeratinsMaleMiddle AgedPeriodontal IndexProspective StudiesSurgical FlapsTreatment OutcomeDental ImplantsIntercellular Signaling Peptides and ProteinsKeratinsApically repositioned flapConcentrated growth factorDental implantsKeratinized mucosaVestibule of the mouth

Identifiers

PMID40604790
PMCPMC12225088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.